Analysts Remain Bullish On Gilead Despite Safety Warning
March 24, 2015 at 12:33 PM EDT
Gilead Sciences issued a new warning about its hepatitis C drugs after discovering a dangerous interaction with amiodarone, a drug that monitors heart rhythm. Consequently, Gilead shares slipped more than 3% on the morning of March 23.
